Form 4 for EW Edwards Lifesciences
Accepted 2023-03-14 00:00:00 ET · period of report 2023-02-15 · accession 0001225208-23-003876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-14 | 2023-03-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $77.61 | -19.9K | 81.1K | -20% | -$1.54M |
| DMI | 2023-03-14 | 2023-02-15+ | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +105.9K | 3.60M | +3% | $0 |
| DM | 2023-03-14 | 2023-02-15+ | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -105.9K | 60.9K | -63% | $0 |
| D | 2023-03-14 | 2023-03-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $35.20 | +29.4K | 90.3K | +48% | +$1.03M |
| D | 2023-03-14 | 2023-03-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $0.00 | -29.4K | 58.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-14 | S | D | 10,700 | $77.86 | 60,947.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $77.625 to $78.170 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-02-15 | G | A | 96,405 | $0.00 | 3,588,422 | I | — | — | |
| 3 | Common | Common Stock | 2023-03-14 | G | D | 9,500 | $0.00 | 71,647.82 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-14 | S | D | 9,175 | $77.32 | 81,147.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $76.620 to $77.620 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2023-03-14 | G | A | 9,500 | $0.00 | 3,597,922 | I | — | — | |
| 6 | Common | Common Stock | 2023-02-15 | G | D | 96,405 | $0.00 | 60,947.82 | D By Living Trust | — | — | |
| 7 | Common | Common Stock | 2023-03-14 | M | A | 29,375 | $35.20 | 90,322.82 | D By Living Trust | — | — | |
| 8 | Derivative | Employee Stock Option (Right to Acquire) | 2023-03-14 | M | D | 29,375 | $0.00 | 58,750 | D | $35.20 · 2016-06-12 to 2023-05-11 | 29,375 Common Stock |